BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2184 related articles for article (PubMed ID: 11238486)

  • 1. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters.
    Lanes R; Soros A; Flores K; Gunczler P; Carrillo E; Bandel J
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3978-82. PubMed ID: 15870123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration.
    Gunczler P; Lanes R; Lopez E; Esaa S; Villarroel O; Revel-Chion R
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):181-6. PubMed ID: 11874183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement.
    Colao A; Di Somma C; Rota F; Di Maio S; Salerno M; Klain A; Spiezia S; Lombardi G
    J Clin Endocrinol Metab; 2005 May; 90(5):2659-65. PubMed ID: 15713715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement.
    Soares DV; Spina LD; de Lima Oliveira Brasil RR; da Silva EM; Lobo PM; Salles E; Coeli CM; Conceição FL; Vaisman M
    Metabolism; 2005 Mar; 54(3):321-9. PubMed ID: 15736109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular risk of GH-deficient adolescents.
    Colao A; Di Somma C; Salerno M; Spinelli L; Orio F; Lombardi G
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3650-5. PubMed ID: 12161490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A; Cuocolo A; Di Somma C; Cerbone G; Della Morte AM; Nicolai E; Lucci R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency.
    Capaldo B; Patti L; Oliviero U; Longobardi S; Pardo F; Vitale F; Fazio S; Di Rella F; Biondi B; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1997 May; 82(5):1378-81. PubMed ID: 9141519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
    Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
    Pfeifer M; Verhovec R; Zizek B; Prezelj J; Poredos P; Clayton RN
    J Clin Endocrinol Metab; 1999 Feb; 84(2):453-7. PubMed ID: 10022400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
    Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
    Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 110.